Andrew Ryan Brodkin

Andrew Brodkin is a partner and a member of the Executive Committee at Goodmans. Andrew also heads the Litigation and Dispute Resolution Group and is co-chair of Goodmans Intellectual Property Group. He focusses his practice on high stakes intellectual property litigation where he has been described as “ having had more successes than anyone in this practice area in history ” ( Lexology Index ) and as “the undisputed IP litigator in Canada” ( Chambers Canada ) .

Andrew has been named "IP – Patents Lawyer of the Year" at the Lexology Index Awards 2026, “Patent Litigator of the Year – Canada” at the LMG Life Sciences Americas Awards 2026 and 2024, “Canada Practitioner of the Year – Patent Disputes” at the Managing IP Awards Americas 2025 and 2024, “Lawyer of the Year” for Intellectual Property Law by The Best Lawyers in Canada 2027 and 2025, and “Intellectual Property Litigator of the Year” at the Benchmark Canada Awards 2024.

Andrew also advises pharmaceutical clients regarding pricing regulation issues, including those relating to the Patented Medicines Prices Review Board (“PMPRB”).

Beyond his intellectual property practice, Andrew has extensive experience in litigation involving provincial and federal governments, having secured a rare finding of liability against the federal government for misfeasance in public office.

Outside of his litigation practice, Andrew has acted as co-counsel to the National Hockey League Officials’ Association in the negotiation of its collective agreement with the National Hockey League.

Andrew has chaired and participated in conferences on IP issues and is a lecturer for the LL.M. Health Law IP course at Osgoode Hall Law School.